Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Roche Boasts Of Tecentriq's Broad Potential In 3Q Earnings Update

Oct 20 2016

• By Lucie Ellis-Taitt

Related Content

For Roche Immuno-Oncology, It’s Steady As She Goes

Jun 24 2016

Genentech’s Tecentriq Stakes New Claim With FDA Lung Cancer Approval

Oct 19 2016

Roche: OAK Data Differentiates Tecentriq In Second-Line Lung Cancer

Oct 10 2016

Related Companies

Roche Holding AG

Merck & Co., Inc.

Bristol Myers Squibb Company

Additional Topics

Sales & Earnings Companies Commercial Cancer BioPharmaceutical

More from Earnings

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window